Industria
Patent Application by TJP Labs Inc. Signals Breakthrough in Nicotine Pouch Technology
With the meteoric rise of the nicotine pouch market as a safer alternative, TJP Labs is well-positioned to capitalize on the industry's race for innovation, meeting and surpassing the rising demand with superior, cutting-edge products. The newly developed particulate marks a critical breakthrough in Nicotine Replacement Therapies.
"This landmark initiative powerfully showcases TJP Labs' commitment to redefining nicotine consumption through innovation," said David Richmond-Peck , Chief Relationship Officer of TJP Labs. "With other innovations in our pipeline, safeguarding our intellectual property remains integral to our strategy, matching our innovative efforts with consumers' evolving preferences," he added.
TJP Labs anticipates the availability of initial evaluation data for these particulates by late the second quarter of 2024. TJP Labs remains dedicated to relentlessly pursuing advancements that enhance the lives of individuals seeking to responsibly manage their consumption of nicotine.
TJP Labs Inc., a wholly owned subsidiary of KIK ASS Products Inc., is North America's leading full-service contract manufacturer of premier next-generation products focusing on modern oral nicotine. It provides contract manufacturing services to an affiliated company that focuses on energy products, including caffeine.
Our products are manufactured and packaged in our DEL, cGMP compliant, ISO 9001:2015 certified state-of-the-art facilities.
For more information about TJP Labs and the innovative nicotine particulate, please contact innovation@tjplabs.com
Logo - https://mma.prnewswire.com/media/2384807/TJP_Labs_Inc__Patent_Application_by_TJP_Labs_Inc__Signals_Breakt.jpg
View original content:https://www.prnewswire.co.uk/news-releases/patent-application-by-tjp-labs-inc-signals-breakthrough-in-nicotine-pouch-technology-302114591.html